Waterless Beauty and Olive Tree People Achieves over 2000% Q1 Growth and 450% Q1 Growth for Oliveda International, Inc.
16 mai 2024 08h33 HE
|
Oliveda International, Inc.
SANTA MONICA, CA, May 16, 2024 (GLOBE NEWSWIRE) -- Oliveda International, Inc. (OTC Pink: OLVI) today announced that the waterless beauty movement and subsidiary, Olive Tree People Inc., are growing...
Cancer Biomarkers Market is Expected to Reach $42.0 billion | MarketsandMarkets™
16 mai 2024 08h30 HE
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, May 16, 2024 (GLOBE NEWSWIRE) -- Cancer Biomarkers market in terms of revenue was estimated to be worth $24.5 billion in 2024 and is poised to reach $42.0 billion by 2029, growing at a CAGR...
Study Shows High Volume Exercise Unrelated to Progression of Coronary Artery Calcium
15 mai 2024 12h17 HE
|
Cooper Aerobics
New research from The Cooper Institute® + partners shows exercising, even at very high levels, is unrelated to progression of coronary artery calcium (CAC)
Venture Partnership: Leading Medical Recruitment Agency Secures Coveted Framework Award
15 mai 2024 09h00 HE
|
Venture Partnership
Uxbridge, England, May 15, 2024 (GLOBE NEWSWIRE) -- Venture Partnership, a leading recruitment agency focused on providing permanent and locum doctor staffing solutions to the primary, acute, and...
Oligonucleotide Synthesis Market is Expected to Reach $19.7 billion | MarketsandMarkets™
15 mai 2024 08h30 HE
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, May 15, 2024 (GLOBE NEWSWIRE) -- Oligonucleotide Synthesis market in terms of revenue was estimated to be worth $8.8 billion in 2024 and is poised to reach $19.7 billion by 2029, growing at...
Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents
15 mai 2024 07h32 HE
|
Neuronetics
MALVERN, Pa., May 15, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Lumos Pharma Announces Positive End-of-Phase 2 Meeting with FDA and Reports First Quarter 2024 Financial Results
14 mai 2024 16h15 HE
|
Lumos Pharma, Inc.
Outcome from End-of-Phase 2 Meeting Supportive of a Placebo-Controlled Phase 3 Trial Updated 12 and 24-Month Data from Phase 2 OraGrowtH210 and OraGrowtH212 Trials Continue to Show Oral LUM-201...
Health Canada Approves Saladax’s 5-Fluorouracil Chemotherapy Therapeutic Drug Monitoring (TDM) Test
14 mai 2024 10h00 HE
|
Saladax Biomedical, Inc.
Bethlehem, PA, May 14, 2024 (GLOBE NEWSWIRE) -- Saladax Biomedical, Inc. (Saladax) is pleased to announce that Health Canada has approved Saladax’s 5-Fluorouracil (My5-FU) Assay for sale in Canada...
FEP Heat Shrink Medical Tubing Market worth $208 million by 2029 Globally, at a CAGR of 7.4%, says MarketsandMarkets™
14 mai 2024 04h30 HE
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, May 14, 2024 (GLOBE NEWSWIRE) -- The Global FEP Heat Shrink Medical Tubing Market is projected to grow from USD 145 million in 2024, and it is projected to reach USD 208 million by 2029, at...
Pacific Health Care Organization, Inc. Reports its First Quarter 2024 Results
13 mai 2024 20h22 HE
|
Pacific Health Care Organization, Inc.
Irvine, May 13, 2024 (GLOBE NEWSWIRE) -- Pacific Health Care Organization, Inc., (the “Company”) (OTCQB: PFHO) today filed with the Securities and Exchange Commission (the “Commission”) its...